El valor de la selección de pacientes en NSCLC: tratamiento de segunda línea en pacientes PD-L1 positivo - page 13

KEYNOTE-001: long-term OS by PD-L1 expression
23.1 months median follow-up
Analysis data cut-off: September 18, 2015.
Patients with unknown PD-L1 TPS were excluded.
CI: confidence interval; OS: overall survival; mo: months; PD-L1: programmed cell death ligand 1; TPS: tumour proportion
score; NR: not reached.
Adapted from Hui R
et al
. Presented at ASCO 2016. Poster 9026.
1...,3,4,5,6,7,8,9,10,11,12 14,15,16,17,18,19,20,21,22,23,...43
Powered by FlippingBook